Latest Breaking News On - Board of directors fine foods pharmaceuticals - Page 1 : comparemela.com

The Board of Directors of Fine Foods & Pharmaceuticals N.T.M. S.p.A approved the Group's Interim Financial Report as of 31 March 2024: EBITDA Margin reached 13.5%, exceeding historical levels

The Board of Directors of Fine Foods & Pharmaceuticals N.T.M. S.p.A approved the Group's Interim Financial Report as of 31 March 2024: EBITDA Margin reached 13.5%, exceeding historical levels
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Milan
Lombardia
Italy
Italian
Verdellino-bergamo
Giorgio-ferraris
Pharmaceuticals-business-unit
Fine-foods-pharmaceuticals
Group-net-financial-position
Board-of-directors-fine-foods-pharmaceuticals
International-accounting-standards-board
Contract-development-manufacturing-organisation